Avricore Health (AVCRF) Asset Writedowns and Impairment (2012 - 2020)

Avricore Health has disclosed Asset Writedowns and Impairment across 6 years of filings, most recently posting $137721.6 for Q4 2020.

• In Q4 2020, Asset Writedowns and Impairment changed N/A year-over-year to $137721.6; the TTM figure through Dec 2020 stood at $135587.3 (up 166.97% YoY), while the FY2025 annual figure was $50525.6, down 91.04% from the prior year.
• Asset Writedowns and Impairment rose to $137721.6 in Q4 2020, from $321.93 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for AVCRF reached as high as $256993.0 in Q1 2017 and fell as low as -$895244.4 in Q4 2017.
• The 4-year median for Asset Writedowns and Impairment is -$44941.0 (2017), against an average of -$74076.9.
• Annual changes were most pronounced in 2018 — Asset Writedowns and Impairment sank 252.59% — and 2020, when it surged 113.11%.
• A 4-year view of Asset Writedowns and Impairment shows it stood at -$895244.4 in 2017, then soared by 86.54% to -$120520.6 in 2018, then soared by 97.96% to -$2456.2 in 2019, then jumped by 5707.03% to $137721.6 in 2020.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $137721.6, $321.93, and -$2456.2 for Q4 2020, Q3 2020, and Q3 2019 respectively.